SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PMCO - Promedco

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joseph Strohsahl who wrote (90)8/12/1998 1:25:00 PM
From: Joseph Strohsahl  Read Replies (2) of 106
 
From Yahoo board:
Buyer conlyj
Aug 12 1998
10:50AM EDT

I know " buy on the rumour, sell on the news". However, PMCO had excellant physician growth-220 new providers-great top line growth, great earnings- almost doubled from last year. Most importantly, in a dismal PPM sector, PMCO met earnings estimates. PMCO has established a track record. They are believeable.They met the projections and have 3 acquisitions tucked into the system last qtr, so the growth in revenues , profits and physicians will increase next qtr and for the year.

Better still, share price tanked with the sector, so PMCO is a cheap small cap with predictable top line and earningsgrowth. And NO asia exposure.
Was a buyer this morn on the news. We will see it sell at 20X to 25X earnings within the month

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext